Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Durga Meenakshi Panneerdoss
Observed name:
D. Panneerdoss
Institutions:
The University of Texas at San Antonio Health Science Center,
The University of Texas at San Antonio
Observed institutions:
The University of Texas at San Antonio Health Science Center,
The University of Texas at San Antonio
ORCID:
0009-0001-8162-5277
Observed ORCID:
0009-0001-8162-5277
OpenAlex ID:
A5020865378
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
2023
·
Kristin A. Altwegg
, Uday P. Pratap
, et al.
·
Breast Cancer Research and Treatment
·
7
PDF
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer
2026
·
Suryavathi Viswanadhapalli
, Tae-Kyung Lee
, et al.
·
Oncogene
·
1
PDF
Abstract 2099: PELP1 inhibition enhances the therapeutic efficacy of topoisomerase inhibitors in triple-negative breast cancer
2024
·
Khaled Mohamed Nassar
, John R. Sanchez
, et al.
·
Cancer Research
·
1
ERX-208 Induces Endoplasmic Reticulum Stress and Suppresses DNA Damage Repair to Enhance Chemotherapy Sensitivity
2026
·
Durga Meenakshi Panneerdoss
, Khaled Mohamed Nassar
, et al.
·
Cancer Research Communications
PDF
Abstract 1260: LIPA inhibition enhances the therapeutic efficacy of DNA-damaging agents in ovarian cancer through induction of ER stress and enhancing DNA damage.
2026
·
Durga Meenakshi Panneerdoss
, Tae-Kyung Lee
, et al.
·
Cancer Research
Abstract 3110: Targeting LIF/LIFR signaling with EC359 overcomes chemoresistance and enhances chemotherapy efficacy in ovarian cancer
2026
·
Sonal R. Chaudhari
, Baskaran Subramani
, et al.
·
Cancer Research
Abstract PS4-04-23: Pelp1 inhibition disrupts dna repair and enhances topoisomerase inhibitor efficacy in triple negative breast cancer
2026
·
K. Nassar
, J. Sanchez
, et al.
·
Clinical Cancer Research
EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling
2025
·
William C. Arnold
, Durga Meenakshi Panneerdoss
, et al.
·
Biomolecules
PDF
Novel LIFR-targeted combination therapy to enhance the utility of standard-of-care chemotherapy in treating ovarian cancer
2025
·
Sonal Chaudhari
, Edward Kost
, et al.
·
Gynecologic Oncology
Abstract 5985: Low-grade serous ovarian cancer is effectively treated with a combination of trametinib and LIFR inhibitor therapeutics
2025
·
William C. Arnold
, Durga Meenakshi Panneerdoss
, et al.
·
Cancer Research
Abstract 4194: Inhibiting PELP1 signaling enhances the therapeutic effectiveness of topoisomerase inhibitors in triple-negative breast cancer
2025
·
Khaled Mohamed Nassar
, John R. Sanchez
, et al.
·
Cancer Research
Abstract PO3-26-10: Small molecule inhibitor of PELP1 exhibit cytotoxic effects on breast cancer cells by blocking ribosome biogenesis
2024
·
Xue Yang
, Khaled Mohamed Nassar
, et al.
·
Cancer Research
Abstract 3408: The role of obesity in promoting the LIF/LIFR signaling in triple negative breast cancer
2023
·
Lois Randolph
, Alondra Rodriguez Sanchez
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
9
H-index:
1
I10-index:
Year
Topic
Type